# Replimune Group, Inc.: Form 8-K, filed Sep 19, 2023

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2023-09-19
- Accepted by EDGAR: Sep 19, 2023, 08:15 ET
- Period: 2023-09-19
- Accession: 0001104659-23-101773
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923101773/tm2326363d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465923101773/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465923101773/tm2326363d1_8k.htm

Filed Sep 19, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-101773. Last ingested by Listed: Nov 3, 2026, 23:32 ET. No prices; not investment advice.